HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Q1

This article was originally published in The Rose Sheet

Executive Summary

Net sales of Medicated Dandruff Shampoos increased 20% to $11.8 mil. due to "strong distribution" of Selsun Salon, which launched last fall, Chattem reports April 5. Sales of Selsun Blue were down "primarily due to increased media support and in-store promotional activity among competitive brands," Chattem adds. Medicated Skin Care net sales dropped 4% to $16.6 mil., but were up 13% when excluding pHisoderm, which was divested in 2005. Gold Bond grew 13% behind "strong sales" of Medicated Body Lotion and Ultimate Healing Lotion. Net sales were $84 mil., up 17%, or 23% excluding pHisoderm. Net income rose 70% to $14.8 mil., including a pre-tax gain of $8.6 mil. "related to a recovery, net of legal expenses, in the Dexatrim litigation settlement," Chattem notes...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel